Colony-stimulating factor-1: A potential biomarker for lupus nephritis

Journal of the American Society of Nephrology

Volumn 26, Issue 2, 2015, Pages 379-389

  Menke, Julia ^a   Amann, Kerstin ^b   Cavagna, Lorenzo ^c   Blettner, Maria ^d   Weinmann, Arndt ^a   Schwarting, Andreas ^a   Kelley, Vicki R ^e  

^a Department of Nephrology and Rheumatology ^*  (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN ANTAGONIST; AZATHIOPRINE; COLONY STIMULATING FACTOR 1; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; BIOLOGICAL MARKER;

ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE MARKER; FEMALE; GENE AMPLIFICATION; GLOMERULAR DYSFUNCTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; LONGITUDINAL STUDY; LUPUS ERYTHEMATOSUS NEPHRITIS; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RECURRENT DISEASE; REMISSION; SYSTEMIC LUPUS ERYTHEMATOSUS; ADOLESCENT; ADULT; AGED; BIOPSY; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; DISEASE COURSE; GLOMERULUS; KIDNEY TUBULE; LUPUS NEPHRITIS; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; REPRODUCIBILITY; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; URINE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOMARKERS; BIOPSY; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; KIDNEY GLOMERULUS; KIDNEY TUBULES; LONGITUDINAL STUDIES; LUPUS NEPHRITIS; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84923919649     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013121356     Document Type: Article

References (32)

1. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Mejía JC, Aydintug AO, Chwalinska-Sadowska H, de Ramón E, Fernández-Nebro A, Galeazzi M, Valen M, Mathieu A, Houssiau F, Caro N, Alba P, Ramos-Casals M, Ingelmo M, Hughes GR; European Working Party on Systemic Lupus Erythematosus: Morbidity and mortality in systemic lupus erythematosus during a 10-year period: A comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 82: 299-308, 2003
2. Fiehn C, Hajjar Y, Mueller K, Waldherr R, Ho AD, Andrassy K: Improved clinical outcome of lupus nephritis during the past decade: Importance of early diagnosis and treatment. Ann Rheum Dis 62: 435-439, 2003
3. Mok CC, Ying KY, Tang S, Leung CY, Lee KW, Ng WL, Wong RW, Lau CS: Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis. Arthritis Rheum 50: 2559-2568, 2004
4. Sprangers B, Monahan M, Appel GB: Diagnosis and treatment of lupus nephritis flares - an update. Nat Rev Nephrol 8: 709-717, 2012
5. Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH, Boletis J, Cervera R, Dörner T, Doria A, Ferrario F, Floege J, Houssiau FA, Ioannidis JP, Isenberg DA, Kallenberg CG, Lightstone L, Marks SD, Martini A, Moroni G, Neumann I, Praga M, Schneider M, Starra A, Tesar V, Vasconcelos C, van Vollenhoven RF, Zakharova H, Haubitz M, Gordon C, Jayne D, Boumpas DT; European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association: Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis 71: 1771-1782, 2012
6. Pixley FJ, Stanley ER: CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol 14: 628-638, 2004
7. Menke J, Iwata Y, Rabacal WA, Basu R, Yeung YG, Humphreys BD, Wada T, Schwarting A, Stanley ER, Kelley VR: CSF-1 signals directly to renal tubular epithelial cells tomediate repair inmice. J Clin Invest 119: 2330-2342, 2009
8. Menke J, Rabacal WA, Byrne KT, Iwata Y, Schwartz MM, Stanley ER, Schwarting A, Kelley VR: Circulating CSF-1 promotes monocyte and macrophage phenotypes that enhance lupus nephritis. J Am Soc Nephrol 20: 2581-2592, 2009
9. Yui MA, Brissette WH, Brennan DC, Wuthrich RP, Rubin-Kelley VE: Increased macrophage colony-stimulating factor in neonatal and adult autoimmune MRL-lpr mice. Am J Pathol 139: 255-261, 1991
10. Lenda DM, Stanley ER, Kelley VR: Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice. J Immunol 173: 4744-4754, 2004
11. Moore KJ, Naito T, Martin C, Kelley VR: Enhanced response of macrophages to CSF-1 in autoimmune mice: A gene transfer strategy. J Immunol 157: 433-440, 1996
12. Menke J, Iwata Y, Rabacal WA, Basu R, Stanley ER, Kelley VR: Distinct roles of CSF-1 isoforms in lupus nephritis. J Am Soc Nephrol 22: 1821-1833, 2011
13. Lenda DM, Kikawada E, Stanley ER, Kelley VR: Reduced macrophage recruitment, proliferation, and activation in colony-stimulating factor-1-deficient mice results in decreased tubular apoptosis during renal inflammation. J Immunol 170: 3254-3262, 2003
14. Tesch GH, Schwarting A, Kinoshita K, Lan HY, Rollins BJ, Kelley VR: Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. J Clin Invest 103: 73-80, 1999
15. Ramljak S, Musholt PB, Schipper C, Flacke F, Sieber J, Borchert M, Forst T, Pfutzner A: The precision study: Examining the inter- and intra-assay variability of replicate measurements of BGStar, iBGStar and 12 other blood glucose monitors. Exp Opin Med Diagnostics 7: 511-516, 2013
16. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M: The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15: 241-250, 2004
17. Brunner HI, Bennett MR, Mina R, Suzuki M, Petri M, Kiani AN, Pendl J, Witte D, Ying J, Rovin BH, Devarajan P: Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis. Arthritis Rheum 64: 2687-2697, 2012
18. Reyes-Thomas J, Blanco I, Putterman C: Urinary biomarkers in lupus nephritis. Clin Rev Allergy Immunol 40: 138-150, 2011
19. Mok CC: Biomarkers for lupus nephritis: A critical appraisal. J Biomed Biotechnol 2010: 638413, 2010
20. Schwartz N, Rubinstein T, Burkly LC, Collins CE, Blanco I, Su L, Hojaili B, Mackay M, Aranow C, Stohl W, Rovin BH, Michaelson JS, Putterman C: Urinary TWEAK as a biomarker of lupus nephritis: A multicenter cohort study. Arthritis Res Ther 11: R143, 2009
21. Rubinstein T, Pitashny M, Levine B, Schwartz N, Schwartzman J, Weinstein E, Pego-Reigosa JM, Lu TY, Isenberg D, Rahman A, Putterman C: Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis. Rheumatology (Oxford) 49: 960-971, 2010
22. Tian S, Li J, Wang L, Liu T, Liu H, Cheng G, Liu D, Deng Y, Gou R, Wan Y, Jia J, Chen C: Urinary levels of RANTES and M-CSF are predictors of lupus nephritis flare. Inflam Res 56: 304-310, 2007
23. Yang PT, Xiao WG, Zhao LJ, Lu J, He LM, Kasai H, Ito M: Increase in the level of macrophage colony-stimulating factor in patients with systemic lupus erythematosus. Ann Rheum Dis 67: 429-430, 2008
24. Hinze CH, Suzuki M, Klein-Gitelman M, Passo MH, Olson J, Singer NG, Haines KA, Onel K, O'Neil K, Silverman ED, Tucker L, Ying J, Devarajan P, Brunner HI: Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity. Arthritis Rheum 60: 2772-2781, 2009
25. Yu F, Wu LH, Tan Y, Li LH, Wang CL, Wang WK, Qu Z, Chen MH, Gao JJ, Li ZY, Zheng X, Ao J, Zhu SN, Wang SX, Zhao MH, Zou WZ, Liu G: Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system. Kidney Int 77: 820-829, 2010
26. Hunter MG, Hurwitz S, Bellamy CO, Duffield JS: Quantitative morphometry of lupus nephritis: The significance of collagen, tubular space, and inflammatory in filtrate. Kidney Int 67: 94-102, 2005
27. Hill GS, Delahousse M, Nochy D, Rémy P, Mignon F, Méry JP, Bariéty J: Predictive power of the second renal biopsy in lupus nephritis: Significance of macrophages. Kidney Int 59: 304-316, 2001
28. Yang N, Isbel NM, Nikolic-Paterson DJ, Li Y, Ye R, Atkins RC, Lan HY: Local macrophage proliferation in human glomerulonephritis. Kidney Int 54: 143-151, 1998
29. Hill GS, Delahousse M, Nochy D, Mandet C, Bariéty J: Proteinuria and tubulointerstitial lesions in lupus nephritis. Kidney Int 60: 1893-1903, 2001
30. Zhang X, Nagaraja HN, Nadasdy T, Song H, McKinley A, Prosek J, Kamadana S, Rovin BH: A composite urine biomarker reflects interstitial inflammation in lupus nephritis kidney biopsies. Kidney Int 81: 401-406, 2012
31. Iwata Y, Boström EA, Menke J, Rabacal WA, Morel L, Wada T, Kelley VR: Aberrant macrophages mediate defective kidney repair that triggers nephritis in lupus-susceptible mice. J Immunol 188: 4568-4580, 2012
32. Austin HA 3rd, Boumpas DT, Vaughan EM, Balow JE: Predicting renal outcomes in severe lupus nephritis: Contributions of clinical and histologic data. Kidney Int 45: 544-550, 1994